NPI registry status
Active
2026 NPPES data Pediatric Endocrinology Physician NPI 1851350730 M.D.
Verify on CMS → Carmen Lazala, M.D.
Pediatric Endocrinology Physician in Bronx, New York.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 1,498 in Pediatric Endocrinology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
148
Medicare Part D claims · Pediatric Endocrinology Physician avg: 137
Generic prescribing
57%
generic claims · 43% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$940.58
40 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Carmen Lazala, M.D. filed 148 Medicare Part D claims in 2024 as a Pediatric Endocrinology Physician in Bronx, New York, prescribing 57% generic.
- 148
- Part D claims, 2024
- 57%
- generic prescribing
- $940.58
- industry payments (Sunshine Act)
- ≥34th
- pct by Part D claim volume (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Carmen Lazala, M.D.
Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1851350730), first enumerated 03/21/2006.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 148 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
Board certification signal
Practices in an ABMS-board-eligible specialty; board certification not confirmed in federal records.
- Reported
Industry payment transparency
$940.58 in reported industry payments (40 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- State context
State board disciplinary context
New York statewide board action statistics are published annually — these figures describe aggregate state activity, not Carmen Lazala, M.D.'s individual license status. Verify directly with the state medical board.
Source: NYSBPMC annual report 2023
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
Compare Lazala with other Pediatric Endocrinology Physician providers
Same primary specialty, same federal CMS NPPES roster.
Also enrolled in New York
- Dr. Siham Accacha, M.D. Mineola, NY
- Dr. Chhavi Agarwal, MD Scarsdale, NY
- Dr. Levon Agdere, M.D. Brooklyn, NY
- Dr. Christine Albini, MD, PH Buffalo, NY
- Payal Anand East Setauket, NY
- Dr. Zoltan Antal, MD Bronx, NY
Other specialties in Bronx: Student in an Organized Health Care Education/Training Program (4,582) · Registered Nurse (2,021) · Social Worker (1,974) · Licensed Practical Nurse (1,828)
CMS NPPES provider registry desk
NPI 1851350730 · Pediatric Endocrinology Physician
NPI-10 · ENUM-LEGACY · TAX-NARROW · RX-LIGHT · BOOK-THIN · PHOTO-ENUM
- NPI-10 1851350730
- ENUM-LEGACY 2006
- TAX-NARROW 1,498
- RX-LIGHT 148
- BOOK-THIN 132 in New York
- PHOTO-ENUM Pamela Clark, MD · 2006
Carmen Lazala, M.D.'s Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2024, across all CMS prescribers nationally
148 ≥ 34th percentile 34% of 1,416,883 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2024
◑
Board-eligible specialty (heuristic, not verified)
Carmen Lazala, M.D. practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Carmen Lazala, M.D.?
Quality data not reportedPrimary specialty
Pediatric Endocrinology Physician
Medicare Part D claims
148 8% vs specialty avg
Specialty distribution in New York
How Pediatric Endocrinology Physician compares to other specialties among New York providers
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Pediatric Endocrinology Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1851350730 |
|---|---|
| Specialty | Pediatric Endocrinology Physician |
| Credentials | M.D. |
| Gender | Female |
| NPI Issued | 03/21/2006 |
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Carmen Lazala, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$941
Largest payer
Azurity Pharmaceuticals, Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - New York NYSBPMC 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 - they are NOT specific to Carmen Lazala, M.D.. To verify Carmen Lazala, M.D.'s current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
312
Total board actions, New York 2023
Across 302 cases
3.12
Actions per 1,000 licensees
New York statewide rate
probation
Most common action type
89 cases
NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Above average
Carmen Lazala, M.D. - brand share 43.0%
Pediatric Endocrinology Physician average
43% brand-name claims vs 57% generic, on 148 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
148
Total Claims
$43K
Total Drug Cost
N/A
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 150.133
- Total Day Supply
- 4,442
- Brand vs Generic
- 43% brand / 57% generic
- Brand Drug Cost
- $41K
- Generic Drug Cost
- $1K
Patient Demographics
- Average Patient Age
- 70.2 years
- Avg HCC Risk Score
- 0.79
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Carmen Lazala, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2024
- Mounjaro
Mounjaro
15 claims
- Valsartan
Valsartan
14 claims
- Atorvastatin Calcium
Atorvastatin Calcium
13 claims
- Carvedilol
Carvedilol
13 claims
- Eliquis
Eliquis
13 claims
- Jardiance
Jardiance
13 claims
- Omeprazole
Omeprazole
13 claims
- Spironolactone
Spironolactone
13 claims
| Drug | Claims |
|---|---|
| Mounjaro Tirzepatide | 15 |
| Valsartan | 14 |
| Atorvastatin Calcium | 13 |
| Carvedilol | 13 |
| Eliquis Apixaban | 13 |
| Jardiance Empagliflozin | 13 |
| Omeprazole | 13 |
| Spironolactone | 13 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Pediatric Endocrinology Physician Overview
How Carmen Lazala, M.D. fits within the Pediatric Endocrinology Physician landscape nationally.
1,498
Pediatric Endocrinology Physician Providers in US
51
States with Pediatric Endocrinology Physician
137
Avg Claims per Provider
Carmen Lazala, M.D.'s 148 claims are above the specialty average of 137.
Nationwide Pediatric Endocrinology Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Lazala, both outside New York so the neighborhoods are not geographic containment.
Same NPPES enumeration year (2006)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Pediatric Endocrinology Physician Providers in New York
Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as Lazala.
One of 132 Pediatric Endocrinology Physician providers enrolled in New York, 11 are shown on this page.
Dr. Jennifer Apsan
M.D.
New Hyde Park, NY
Dr. Gaya Aranoff
MD
New York, NY
Dr. Henry Artman
MD
Rochester, NY
Dr. Shreshtha Banga
MD
Brooklyn, NY
Dr. Renee Bargman
MD
New York, NY
Compare Pediatric Endocrinology Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Carmen Lazala, M.D.'s specialty? ▼
Carmen Lazala, M.D. specializes in Pediatric Endocrinology Physician and practices in Bronx, New York. Credentials: M.D..
How much does Carmen Lazala, M.D. prescribe under Medicare Part D? ▼
In 2024, Carmen Lazala, M.D. wrote 148 Medicare Part D claims totaling $43K in drug costs for N/A beneficiaries.
Where is Carmen Lazala, M.D. located? ▼
Carmen Lazala, M.D. is located at 2676B GRAND CONCOURSE, Bronx, NY, 10458. Phone: (718) 220-6272.
What is Carmen Lazala, M.D.'s NPI number? ▼
Carmen Lazala, M.D.'s National Provider Identifier (NPI) is 1851350730, issued on 03/21/2006.
Does Carmen Lazala, M.D. prescribe more brand-name or generic drugs? ▼
Carmen Lazala, M.D.'s prescribing is 43% brand-name and 57% generic drugs by claim count, with $41K in brand drug costs.
How many Pediatric Endocrinology Physician providers are there in the US? ▼
There are 1,498 Pediatric Endocrinology Physician providers across 51 states in the US. The average Pediatric Endocrinology Physician provider writes 137 Medicare Part D claims per year.
What drugs does Carmen Lazala, M.D. prescribe most often? ▼
Based on 2024 Medicare Part D data, Carmen Lazala, M.D.'s most frequently prescribed drugs include Mounjaro, Valsartan, Atorvastatin Calcium. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Carmen Lazala, M.D. accept Medicare? ▼
Carmen Lazala, M.D. appears in CMS Medicare data with 148 Part D claims and N/A Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Carmen Lazala, M.D.'s credentials? ▼
Carmen Lazala, M.D.'s NPI is 1851350730 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.